SCHEMBL22011694

SCHEMBL22011694

c1ccc(-c2nc(-c3ccccc3)nc(-n3c4ccccc4c4c5sc6ccccc6c5c5c(ccc6c5c5ccccc5n6-c5ccccc5)c43)n2)cc1

nearest known ligand 0.42

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.34
ATM Q13315 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16866925 0.89 L3MBTL1 (0.36) KDM4EATML3MBTL1
SCHEMBL17406183 0.89 L3MBTL1 (0.36) KDM4EATML3MBTL1
SCHEMBL22011451 0.89
SCHEMBL22012991 0.88 ALDH1A1 (0.37) KDM4EATML3MBTL1
SCHEMBL16275555 0.87 L3MBTL1 (0.36) KDM4EATML3MBTL1
SCHEMBL16275760 0.87 L3MBTL1 (0.36) KDM4EATML3MBTL1
SCHEMBL19961613 0.86 CYP1A1 (0.30)
SCHEMBL22011691 0.86 L3MBTL1 (0.40) KDM4EATML3MBTL1
SCHEMBL17405415 0.86 EGLN1 (0.32) KDM4EATML3MBTL1
SCHEMBL17405764 0.85 L3MBTL1 (0.36) KDM4EATML3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12035625-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2024-07-09 US disclosed
US-12035625-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2024-07-09 US disclosed
EP-3880682-B1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2023-06-14 EP disclosed
US-20220006030-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2022-01-06 US disclosed
WO-2020099307-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2020-05-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220006030-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES ZYX, RER1, AOC2 KDM4E 1792/4885ATM 1787/4885L3MBTL1 2301/4885
US-12035625-B2 Materials for organic electroluminescent devices ZYX, RER1, AOC2 KDM4E 1792/4885ATM 1787/4885L3MBTL1 2301/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.